Skip to the page

Data / Form D filings / NK-One Therapeutics, Inc.

NK-One Therapeutics, Inc.: Form D filing

NK-One Therapeutics, Inc., a biotechnology company in Wayne, PA, filed a Form D with the SEC in 2026. The latest, on April 27, 2026, reports $290,000 sold of a $310,000 offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
526 PARK RIDGE DRIVE, Wayne, PA, 19087
Phone
(610) 733-0446
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2026
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2127553

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 27, 2026New notice$310,000$290,000$20,0007Mar 4, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Michael ShineExecutive Officer, DirectorChief Executive Officer and President
Marco PappagalloExecutive Officer, DirectorSecretary

Other biotechnology companies in Pennsylvania that filed recently

Every Form D from the week of Apr 27, 2026 · All recent filings in Pennsylvania · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what NK-One Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.